Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease

By afschroeder • July 10, 2025

Fine SA, Lim SY, Siena NM, de Jesus AB, Goh T, Markus L, Russell TA, Kendal JK, Lofftus SY, Shehata MS, Dao HB, Lee A, Klingbeil KD, Kadera BE, Chmielowski B, Nelson SD, Dry SM, Bernthal NM, Singh AS, Reddy VK, Kalbasi A, Wessel LE, Prins RM, Eilber FR, Eilber FC, McCaw TR, Crompton JG. Incomplete Cancer Surgery Correlates With Loss of Immune Surveillance and Hyper-Progression of Disease. J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70023. Epub ahead of print. PMID: 40631605.

Tags: Hematology/Oncology, hyper‐progression, immunosuppression, myeloid‐derived suppressor cell, oncologic surgery, Publications, regulatory T cell, soft tissue sarcoma, tumor microenvironment

IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy

Jiang H, Limsuwannarot S, Kulhanek KR, Pal A, Labiad O, Rysavy LW, Wong A, Su L, Cavender S, Soro J, Testa S, Ogana H, Waghray[...]

Mammary small cell neuroendocrine carcinomas that showed excellent pathologic response following etoposide-based neoadjuvant chemotherapy

Hammer PM, Enamandram S, Ikeda DM, Lam MM, Wapnir IL, Chamberlain ED, Shaheen S, Caswell-Jin JL, Itakura H, Bean GR. Mammary small cell neuroendocrine carcinomas[...]

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis

Zaorsky NG, Sun Y, Nabid A, Zapatero A, Bolla M, Joseph D, Maingon P, Guerrero A, Gonzalez AA, San-Segundo CG, Cabeza Rodríguez MÁ, Sole JM,[...]